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Abstract
Background:  Global cardiovascular risk is a new approach which allows the physicians to
quantitate the prognosis of the patients. It is therefore possible that a score, based on the major
cardiovascular risk factors, is correlated with some degree of cardiovascular anatomic damage.
Since this hypothesis has been demonstrated with the Framingham risk score, we decided to verify
it using another score (Progetto Cuore risk score), which is probably more precise in a european
low-risk population, such as the italian one.
Methods: We studied 84 italian caucasian subjects (50 males and 34 females) with elevated blood
pressure and/or dyslipidemia plus other possible cardiovascular risk factors.
The subjects have never been treated for these reasons. The following evaluations were
performed: history, clinical and laboratory determinations, echocardiogram, carotid echodoppler.
Results: The recruited people were on the whole characterized by a low cardiovascular risk, as
confirmed by the low scores of the Progetto Cuore. Simple linear regression analysis showed
significant associations between some parameters of early cardiovascular damage (left ventricular
mass, intima-media thickness, and an integrated measure of both the carotid wall thickness and the
presence of a plaque, called Carotid score) and some predictors. The highest significance was found
between the cardiovascular structural results and the Progetto Cuore score. In a multivariate
regression analysis our model, which included factors potentially linked to the cardiovascular
anatomic changes, demonstrated that the Carotid score was significantly associated with age, sex
and pulse pressure; intima-media thickness with the same factors and, in addition, with the body
mass index; left ventricular mass with sex, pulse pressure and body mass index.
Conclusion:  Our paper confirms previous studies about the association between a
comprehensive risk score and signs of early cardiovascular damage. A temporally limited exposure
to cardiovascular risk factors, in particular to blood pressure, is already able to induce significant
changes in both the heart structure and the vascular wall. Also in a european low-risk population
the use of a cardiovascular risk score program, such as the Progetto Cuore in Italy, allows a quite
precise estimation of the possible cardiovascular damage.
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Background
The concept of global cardiovascular risk has been widely
accepted in medicine: the patient is no more considered as
a carrier of single cardiovascular risk factors, to be tackled
one by one by the physician, but as a subject potentially
affected by their interactions. This approach was proposed
in 2003 by the guidelines of the European Society of
Hypertension and the European Society of Cardiology [1],
in partial disagreement with those written in the same
year by the american hypertension specialists, which put
the blood pressure values only as reference for the begin-
ning of the anti-hypertensive therapy [2].
In support of this new approach in the last few years many
projects were developed (in Italy named Progetto Cuore)
in order to provide the practising physician a quantifica-
tion of the cardiovascular risk of the single patient
through a computerized procedure based on the acquisi-
tion of clinical parameters, such as age, sex, blood pres-
sure values, lipid status, and smoking habits.
In order to evaluate the impact of different risk factors on
target organs and the possible correlations with the italian
risk score Progetto Cuore, we decided to study subjects
sent to our outpatient clinic by the general practitioners.
Our outpatient clinic is devoted to patients with dyslipi-
demia and hypertension: we could therefore choose to
evaluate subjects with two important cardiovascular risk
factors, such as high blood pressure and/or abnormal
lipid values, but without previous or concomitant thera-
pies.
Methods
Since February 2007 through September 2007 we studied
84 caucasian subjects (50 males and 34 females) affected
by blood pressure above normal levels (high normal
blood pressure or hypertension) and/or dyslipidemia,
sent to our outpatient clinic by the general practitioners in
a local survey of the prevalence of the metabolic syn-
drome.
The inclusion criteria are shown in Table 1. In all subjects
we obtained a history, a complete clinical examination,
fasting blood and urine samples, and we performed a B-
mode echocardiogram and a carotid echodoppler. The
clinical parameters obtained with this approach are
shown in Table 2. Blood pressure and heart rate are
expressed as means of three values measured consecu-
tively by a mercury sphygmomanometer and at the radial
artery, respectively.
Global cardiovascular risk at 10 years was evaluated using
the Progetto Cuore program of the Istituto Superiore di
Sanità http://www.cuore.iss.it: this score is calculated tak-
ing into account some variables such as sex, age, smoking
habits, systolic and diastolic blood pressure, total choles-
terol levels, HDL-cholesterol levels, and possible anti-
hypertensive therapy.
The metabolic syndrome was defined using the criteria of
the National Cholesterol Education Program – Adult
Treatment Panel III (NCEP-ATP III) [3].
All the echocardiogram examinations were performed by
the same experienced cardiologist using an ATL model
HDI 5000 B-mode echocardiograph with a 3.5 MHz sec-
torial probe. Registrations were performed along the long
axis parasternal projection with the M-mode measure-
ment of the left atrium, aortic root, and left ventricle (end
diastolic and end systolic thickness of both the ventricular
septum and the posterior wall, end diastolic and end
systolic diameters of the left ventricle). The doppler regis-
tration of the transmitralic profile was performed in the
apical projection. Left ventricle mass (LVM) was deter-
mined calculating the left ventricle mass (according to the
formula of the American Society of Echocardiography)
[4]. The relative wall thickness of the left ventricle was cal-
culated as the ratio between the double of the end diasto-
lic posterior wall and the chamber diameter.
All the carotid echodopplers were performed by the same
physician using ESAOTE model AU5 with a 7.5 MHz lin-
ear probe. The examination of the subjects, in supine posi-
tion and with the extrarotated head contralaterally by
45°C, evaluated the common carotid artery, the carotid
bifurcation and the extracranial tracts of both the internal
and external carotids with a longitudinal and transverse
approach. Intima-media thickness was determined in tel-
ediastole at the level of the far wall of the common carotid
artery at a distance of 20-10-5 mm from the bifurcation.
Table 1: Inclusion criteria
Age between 35 and 75 years
Presence of blood pressure values higher than 130/85 mmHg and/or dyslipidemia (defined according to the ESH/ESC guidelines)
Absence of previous or concomitant drug treatments
Absence of secondary hypertension and monogenic dyslipidemia
Absence of serious pulmonary, renal, hepatic, gastrointestinal, endocrine, immunologic, neoplastic diseases
Absence of previous cardiovascular diseases
Absence of diabetes mellitus
Absence of pregnancyCardiovascular Ultrasound 2008, 6:47 http://www.cardiovascularultrasound.com/content/6/1/47
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For statistical analysis the mean of the three measure-
ments in both common carotid arteries (defined as mean
intima-media thickness, m-IMT) was used. According to
the ESH/ESC guidelines an intima-media thickness lower
than 0.9 mm was considered normal; a thickness higher
than 0.9 mm but lower than 1.3 was considered increased;
a thickness higher than 1.3 mm was defined as a plaque
[1]. Based on these definitions, we calculated a Carotid
score giving 1 point (presence of plaque), 0.5 point (pres-
ence of increased intima-media thickness) and 0 points
(absence of lesions): the final score was the sum of the
possible lesions in 10 sites (3 at common carotid artery
and at the bifurcation, 1 at internal carotid artery, and 1 at
external carotid artery on both sides).
Statistical analysis was carried out using Statistica 8.0
package (StatSoft Inc., Tulsa, OK, USA). For statistical pur-
poses the Progetto Cuore scores were log-transformed to
reduce skewness.
Results
The clinical characteristics of the subjects studied are
shown in Tables 2 and 3. As we already mentioned, we
evaluated subjects without previous treatments for hyper-
tension and dyslipidemia. Since the inclusion criteria
allowed the recruitment of subjects with mild increases of
blood pressure and lipid values, our population was on
the whole characterized by not advanced age, high normal
mean blood pressure values, and not very high mean
serum levels of total cholesterol and triglycerides.
These characteristics were confirmed by the cardiovascular
risk scores calculated for our subjects: mean value was
5.16 ± 5.3 SD, and only 2 of them (2%) were above 20%
risk of cardiovascular events at 10 years (i.e. high cardio-
vascular risk according to the Progetto Cuore score).
Simple linear regression analysis showed significant asso-
ciations between some responses (Carotid score, m-IMT,
LVM) and some predictors (Table 4 and Figure 1). Instead
urinary albumin/creatinine ratio and relative wall thick-
ness demonstrated no significant associations with any
independent variable (data not shown). When we evalu-
ated the possible associations between an integrated
measurement such as the Progetto Cuore score and the
previous dependent variables we found a very high signif-
icance with the Carotid score, the m-IMT, and the LVM.
We also divided the subjects according to the sex: in both
male (Table 5) and female (Table 6) subjects we con-
firmed some significant associations but again the highest
one was between the Carotid score and the Progetto
Cuore score.
In a multivariate regression analysis (Table 7), we used a
model which included factors potentially linked to the
Carotid score, to the m-IMT, to the left ventricle mass, and
to the urinary albumin/creatinine ratio. For the Carotid
score age, sex and pulse pressure maintained a significant
association; for the m-IMT there was a low significance
also with body mass index. On the contrary sex, pulse
pressure and body mass index showed a significant asso-
ciation with the LVM.
Table 2: Clinical characteristics of the subjects
Number 84
Sex (Males/Females) 50/34 (59/41%)
Hypertension (Yes/No) 48/36 (57/43%)
Grades of Hypertension:
1 35 (73%)
2 12 (25%)
3 1 (2%)
Types of Dyslipidemia:
Total Cholesterol > 190 73 (87%)
HDL Cholesterol < 40 19 (23%)
Triglycerides > 150 62 (74%)
Smoke (Yes/No) 24/60 (29/71%)
Metabolic Syndrome (Yes/No) 36/48 (43/57%)
Table 3: Parameters of the subjects
Mean SD
Age (years) 52.5 10.05
Weight (kg) 77.53 16.64
Height (cm) 169.67 9.94
Body Mass Index (kg/m2) 26.78 4.41
Waist Circumference (cm) 96.47 13.51
Systolic Blood Pressure (mmHg) 137.34 14.79
Diastolic Blood Pressure (mmHg) 88.2 9.43
Pulse Pressure (mmHg) 49.14 10.26
Heart Rate (bpm) 74.32 8.84
Total Cholesterol (mg/dl) 246.76 49.7
HDL Cholesterol (mg/dl) 52.99 15.7
Total/HDL Cholesterol Ratio 4.94 1.37
Triglycerides (mg/dl) 202.38 85
Glucose (mg/dl) 86.83 13.39
Insulin (μU/ml) 9.86 9.12
Creatinine (mg/dl) 0.85 0.16
Uric Acid (mg/dl) 5.44 1.48
Components of the Metabolic Syndrome 2.29 0.99
Urinary Albumin/Creatinine Ratio (mg/g) 13.92 16.61
Left Ventricle Mass (g) 146.08 40.9
Relative Wall Thickness 0.34 0.08
m-IMT (mm) 0.81 0.22
Carotid Score (A.U.) 2.02 1.77
Progetto Cuore Score 5.16 5.3Cardiovascular Ultrasound 2008, 6:47 http://www.cardiovascularultrasound.com/content/6/1/47
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Univariate correlations between the logarithmic transformation of the Progetto Cuore score (LogCUORE) and the mean  intima-media thickness (m-IMT), the Carotid score, and the left ventricular mass (LVM) in all subjects (n. = 84) Figure 1
Univariate correlations between the logarithmic transformation of the Progetto Cuore score (LogCUORE) 
and the mean intima-media thickness (m-IMT), the Carotid score, and the left ventricular mass (LVM) in all 
subjects (n. = 84).
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Table 4: Simple regression analysis – All subjects. Only significant associations are shown.
Variable Carotid Score m-IMT Left Ventricular Mass
Age r = 0.41
p < 0.001
r = 0.23
p < 0.05
-
Weight -r  =  0 . 2 3
p < 0.05
r = 0.75
p < 0.00001
Height - - r = 0.53
p < 0.0001
Body Mass Index - - r = 0.58
p < 00001
Waist Circumference -r  =  0 . 2 2
p < 0.05
r = 0.66
p < 0.00001
Systolic BP r = 0.26
p < 0.05
r = 0.27
p < 0.01
r = 0.29
r < 0.01
Diastolic BP - - r = 0.26
p < 0.02
Pulse Pressure r = 0.28
p < 0.05
r = 0.3
p < 0.01
-
Heart Rate -- -
Total Cholesterol - - r = -0.28
p < 0.01
HDL Cholesterol - - r = -030
p < 0.01
Total/HDL Ratio -- -
Triglycerides -- -
Glucose -- -
Insulin - - r = 0.34
p < 0.01
Creatinine - - r = 0.24
p < 0.05
Uric acid - - r = 0.46
p < 0.0001
Progetto Cuore
Score
r = 0.46
p < 0.001
r = 0.27
p < 0.02
r = 0.28
p < 0.01
Progetto Cuore
Score – Logarithm
r = 0.48
p < 0.00001
r = 0.3
p < 0.01
r = 0.27
p < 0.02Cardiovascular Ultrasound 2008, 6:47 http://www.cardiovascularultrasound.com/content/6/1/47
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In addition m-IMT was significantly associated with LVM
when we considered all the subjects; this association was
confirmed in female subjects, instead it was not seen in
male subjects (Table 8).
As a final point, the presence of the metabolic syndrome
was not able to induce a higher level of damage at the car-
diovascular sites (data not shown).
Discussion
Our results show that, in a population with some cardio-
vascular risk factors but, as a whole, not at particularly
high risk, it is possible to demonstrate a significant corre-
lation between a simple risk score, used in clinical practice
by italian physicians, and some parameters of target organ
damage. This was something already demonstrated with
the Framingham risk score and confirmed by recent
papers [5-7]. However it is well known that this cardiovas-
cular score does not fit perfectly to our population with a
tendency to the overestimation of the risk [8,9]: this is the
main reason we decided to evaluate the correlation
between target organ damage and the Progetto Cuore risk
score.
In addition, the absence of the effects of any anti-hyper-
tensive and hypolipemic therapy allows us to exclude pos-
sible drug effects in terms of reversal of the anatomic
damage: this is something the other studies, although
with more subjects, had to take into account.
Our population can be considered at not very long expo-
sure of traditional risk factors: this can be inferred by the
absence of drug therapy for hypertension or dyslipidemia.
In fact all the subjects studied in this study were regularly
evaluated by their family physicians and, at the appear-
ance of an increase of blood pressure or blood lipids, rap-
idly sent to our clinic. In addition the age and the absolute
levels of those parameters put our subjects on average at
low risk of cardiovascular events; again in other studies all
the categories of risk were included.
Our clinical evaluations allow to find interesting associa-
tions. The most significant is the association between Pro-
getto Cuore score and the Carotid score: the associations
with m-IMT and LVM were less significant. The reason we
used the Carotid score in order to define the damage of
the vascular wall was related to the possible different
meanings of the intima-media thickness and the plaques
Table 5: Simple regression analysis – Male subjects (n = 50). Only significant associations are shown.
Variable Carotid Score m-IMT Left Ventricular Mass
Age r = 0.49
p < 0.001
--
Weight - - r = 0.70
p < 0.00001
Height -- -
Body Mass Index - - r = 0.65
p < 00001
Waist Circumference - - r = 0.64
p < 0.00001
Systolic BP r = 0.29
p < 0.05
r = 0.33
p < 0.05
r = 0.32
r < 0.05
Diastolic BP -- -
Pulse Pressure r = 0.38
p < 0.01
r = 0.34
p < 0.05
-
Heart Rate -- -
Total Cholesterol -- -
HDL Cholesterol -- -
Total/HDL Ratio -- -
Triglycerides -- -
Glucose -- -
Insulin - - r = 0.31
p < 0.05
Creatinine -- -
Uric acid - - r = 0.30
p < 0.05
Progetto Cuore
Score
r = 0.46
p < 0.001
--
Progetto Cuore
Score – Logarithm
r = 0.44
p < 0.01
--Cardiovascular Ultrasound 2008, 6:47 http://www.cardiovascularultrasound.com/content/6/1/47
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[10,11]: in fact the increase of the intima-media thickness
could represent a hypertrophic response of intimal and
medial cells to vascular risk factors (hypertension, dyslip-
idemia); instead the atherosclerotic plaques could repre-
sent a later stage of vascular damage related to endothelial
dysfunction and inflammation. A possible confirmation
of this hypothesis is the presence of a significant relation-
ship between m-IMT and LVM (another parameter mainly
affected by the blood pressure levels), but not between
LVM and Carotid score: previous studies showed that IMT
was more closely associated with LVM than with coronary
artery disease [12,13]. The use of a score for the evaluation
of the carotid walls was proposed by some groups [14,15];
others suggested the determination of the plaque area
[16].
When we performed the simple regression analysis, as a
first step we evaluated the all subjects finding the signifi-
cant associations shown in Table 4. Subsequently we
divided the subjects by sex and we could not confirm all
the statistical significances: however Progetto Cuore score
maintained a significant association with the Carotid
score in both sexes.
The multiple regression analysis was carried out defining
a model with possible variables potentially related to both
vascular and cardiac damage: for Carotid score we found
Table 6: Simple regression analysis – Female subjects (n = 34). Only significant associations are shown.
Variable Carotid Score m-IMT Left Ventricular Mass
Age r = 0.53
p < 0.01
r = 0.46
p < 0.01
-
Weight - - r = 0.53
p < 0.01
Height - - r = 0.38
p < 0.05
Body Mass Index -- -
Waist Circumference - - r = 0.57
p < 0.001
Systolic BP -- -
Diastolic BP -- -
Pulse Pressure -- -
Heart Rate -- -
Total Cholesterol -- -
HDL Cholesterol -- -
Total/HDL Ratio -- -
Triglycerides -- -
Glucose -- -
Insulin -- -
Creatinine -- -
Uric acid -- -
Progetto Cuore
Score
r = 0.55
p < 0.001
r = 0.36
p < 0.05
-
Progetto Cuore
Score – Logarithm
r = 0.54
p < 0.01
r = 0.43
p < 0.05
-
Table 7: Multiple regression analysis. Only significant associations are shown.
Variable Carotid Score m-IMT Left Ventricular Mass
Age β = 0.542
p < 0.00001
β = 0.336
p < 0.01
-
Sex β = 0.301
p < 0.01
β = 0.236
p < 0.05
β = 0.406
p < 0.0001
Pulse Pressure β = 0.191
p < 0.05
β = 0.235
p < 0.05
β = 0.166
p < 0.05
Tot/HDL Ratio -- -
Glucose -- -
Body Mass Index - β = 0.274
p < 0.05
β = 0.571
p < 0.0001
Smoke -- -Cardiovascular Ultrasound 2008, 6:47 http://www.cardiovascularultrasound.com/content/6/1/47
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significant associations with age, sex and pulse pressure.
As for m-IMT, body mass index was significant in addition
to the above mentioned variables. Instead with regards to
the LVM the significant associations in the multiple
regression analysis were with sex, pulse pressure and body
mass index. These statistical evaluations suggest that,
among modifiable cardiovascular risk factors, blood pres-
sure is more important than cholesterol in inducing initial
damage of heart and vessels.
An apparent contradiction in our results is a better corre-
lation with the Progetto Cuore score exhibited by the
carotid damage with respect to the heart: it is well known
that the left ventricular hypertrophy is a better prognostic
indicator in terms of cardiovascular events. Again we
believe that our particular population (subjects with not a
long exposure to risk factors) can explain this discrepancy.
Only one subject could be considered with left ventricular
hypertrophy (according to the ESH-ESC criteria) and in
this setting of subjects a thorough vascular evaluation can
be more sensitive than the echocardiographic examina-
tion.
A final issue of these results is the presence of rather low
correlation coefficients, although with good statistical sig-
nificance. This is something already shown in similar
studies [7], likely related to the fact that the cardiovascular
damage can be a marker of risk per se, indipendently of the
usual risk factors [17,18].
Conclusion
Our paper confirms previous studies about the associa-
tion between a comprehensive risk score and signs of early
cardiovascular damage. A temporally limited exposure to
cardiovascular risk factors is already able to induce signif-
icant changes in both the heart structure and the vascular
wall. Among the possible risk factors for these changes
blood pressure seems to be the most powerful inducer.
Echographic examination of the cardiovascular system
represents a useful tool for a complete prognostic evalua-
tion of subjects with different risk factors.
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